Cynthia Lynn Anderson
CHIEF FINANCIAL OFFICER · Vistagen Therapeutics, Inc.
Individual
- 2025
- Jun 30, 2025
- 1
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Cynthia Lynn Anderson's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Catalyst4, Inc. - $191.21M in MPLT purchases and sales in the last 12 months
- John Oyler - $189.61M in ONC purchases and sales in the last 12 months
- BVF PARTNERS L P - $173.67M in KYMR purchases and sales in the last 12 months
- BAKER BROS. ADVISORS LP - $172.50M in KYMR purchases and sales in the last 12 months
- Keith S. Manchester - $154.47M in ROIV purchases and sales in the last 12 months
- QVT Financial LP - $147.38M in ROIV purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Cynthia Lynn Anderson?
Cynthia Lynn Anderson is a corporate insider, tracked as CHIEF FINANCIAL OFFICER of Vistagen Therapeutics, Inc. (VTGN). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Cynthia Lynn Anderson last file a Form 4?
The only primary Form 4 on record is dated 30 June 2025.
